Arecor

Arecor collaborates with pharmaceutical and biotech companies who are developing recombinant proteins and vaccines for application in drugs, medical devices or diagnostics. Arecor has developed Arestat™, a smart stabilization technology, which enables the formulation of labile proteins and vaccines as stable aqueous or dry preparations even at high concentrations or in the presence of ionizing radiation. As a simple reformulation, the technology can be readily integrated into existing manufacturing processes. Arestat™ does not involve the covalent modification of biologics and uses only GRAS (Generally Regarded As Safe) excipients approved by relevant regulatory authorities.

Address

Arecor
2, Cambridge Science Park
Milton Road, Cambridge
Cambridgeshire, United Kingdom
CB4 0FE
Telephone: 01223 426060
Fax: 01223 423411
Email:
Web: http://www.arecor.com

Recent News from Arecor